There is no clinically approved treatment for<unk> . First line treatment is usually with antibiotics, specifically with ciprofloxacin and metronidazole. Ampicillin or piperacillin can also be considered as alternatives to empiric ciprofloxacin and metronidazole. Administration of metronidazole at a high daily dose of 20 mg/kg can cause symptomatic peripheral neuropathology in up to 85% of patients. This can be a limiting factor in the use of maintenance metronidazole to suppress chronic<unk> . Other therapies which have been shown to be effective include probiotics, the application of which usually begins as soon as any antibiotic course is completed so as to re-populate the pouch with beneficial bacteria. Biologics, such as anti-tumor necrosis factor antibodies, may also be useful but the evidence for their use is largely anecdotal.
Pouchitis
Cuffitis
Posthitis
Mucocele
Varices
Phlegmon
Blister
Mouth ulcer